Korean scientists have developed a revolutionary eye drop treatment for dry age-related macular degeneration (AMD), ...

A new eye drop therapy offers a non-invasive alternative for treating dry age-related macular degeneration. Massively ...

Dual- and triple-agonist GLP-1s appear to achieve greater weight loss in an overview of clinical trials of approved and ...

Phase 1 results support proceeding to Phase 2 in patients with post-bariatric hypoglycemia (PBH),which is expected to begin in 2H 2025Phase 1 ...

The FDA has approved Liraglutide Injection, the first generic version of Victoza, for the treatment of type 2 diabetes.

Patients were randomly assigned to receive daily subcutaneous injections of replacement ... The authors conclude that C-peptide treatment at a replacement dose for 6 months improves early ...

However, questions remain regarding the potential role for natriuretic peptides to guide therapy in patients with HF. In this Review, we address the underlying assumptions and the existing ...

Recent market research reveals that glucagon-like peptide-1 (GLP-1) injections are set to dominate the obesity treatment ...

Unlike opioids, the new treatment focuses on oxytocin ... In fact, this approach is groundbreaking, as most peptide-based drugs, like insulin, require injections due to their instability in ...

“We are extremely excited to announce our second internal peptide-RI clinical development candidate, PD-29875, targeting CLDN18.2 for the potential diagnosis and treatment of gastric ...